imiquimod has been researched along with Leishmaniasis, Mucocutaneous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Becker, I; Bonifaz, A; Fernández-Figueroa, EA; Fuentes-Nava, G; Sánchez-Montes, S; Tirado-Sánchez, A | 1 |
1 other study(ies) available for imiquimod and Leishmaniasis, Mucocutaneous
| Article | Year |
|---|---|
Efficacy of imiquimod 5% cream as first-line management in cutaneous leishmaniasis caused by Leishmania mexicana.
Topics: Adult; Humans; Imiquimod; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Mexico; Young Adult | 2021 |